Pharmaresources: Announcement of the resolutions of the 17th meeting of the 3rd Board of Directors.
Pharmaresources: 2023 Annual Results Briefing Event Schedule
Pharmaresources: Announcement on holding the 2023 online results briefing
Pharmaresources: CITIC Securities Co., Ltd.'s 2023 follow-up report on Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd.
Pharmaresources: Report by CITIC Securities Co., Ltd. on the continuous supervision and training of Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. in 2023
Pharmaresources: CITIC Securities Co., Ltd. report on the 2023 continuous supervision and regular on-site inspection report of Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd.
Pharmaresources: Announcement of Resolutions of the 11th Meeting of the Third Board of Supervisors
Pharmaresources: Announcement of Resolutions of the 16th Meeting of the Third Board of Directors
Hongbo Pharmaceutical: Special Report on the Storage and Use of Funds Raised in 2023
Hongbo Pharmaceutical: Verification Report on the Special Report on the Deposit and Use of Funds Raised in 2023
Hongbo Pharmaceutical: CITIC Securities Co., Ltd.'s verification opinion on the conclusion of the Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. initial public offering of shares and the use of savings to raise funds to permanently supplement working capital
Hongbo Pharmaceutical: Special opinion of the board of directors on the independent assessment of sole director
Hongbo Pharmaceutical: 2023 Independent Director Debriefing Report (Shao Chunyang)
Hongbo Pharmaceutical: 2023 Independent Director Debriefing Report (You Qidong)
Hongbo Pharmaceutical: 2023 Independent Director Debriefing Report (Cheng Li)
Hongbo Pharmaceutical: Announcement on Using Remaining Overraised Funds to Permanently Replenish Liquidity
Hongbo Pharmaceutical: Verification Opinions of CITIC Securities Co., Ltd. on the 2023 Internal Control Self-Assessment Report of Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd.
Hongbo Pharmaceutical: Special Report on Capital Occupation by Related Parties in 2023
Hongbo Pharmaceutical: Announcement of Board Resolutions
Hongbo Pharmaceutical: CITIC Securities Co., Ltd.'s verification opinion on the use of surplus overraised capital by Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. to permanently supplement working capital
No Data